Drug-Induced Lung Disease (Organizing Pneumonia) Associated with Mesalazine-Reference-Cited by-同舟云学术

Drug-Induced Lung Disease (Organizing Pneumonia) Associated with Mesalazine

Published:2022-02-11 Issue:1 Volume:100 Page:55-60
ISSN:2542-1506
Container-title:Tuberculosis and Lung Diseases
language:
Short-container-title:Tuberk. bolezni lëgk.

Author:

Smirnova E. V.¹,Strelkova D. A.²,Ratchina S. A.³,Avdeev S. N.³,Aryutina O. V.¹,Karpova O. Yu.⁴

Affiliation:

1. Vinogradov City Clinical Hospital

2. RUDN University

3. I. M. Sechenov First Moscow State Medical University (Sechenov University),

4. I. M. Sechenov First Moscow State Medical University (Sechenov University)

Abstract

The article describes a clinical case of mesalazine-related lung disease in a patient treated for ulcerative colitis.

Publisher

LLC "Medical Knowledge and Technologies"

Subject

General Medicine

Reference23 articles.

1. Аvdeev S.N., Chernyaev А.L., Chuchalin А.G. Organizing pneumonia: diagnostics, symptoms and treatment. Terapevt. Arkh., 2012, vol. 84, no. 3, pp. 38-44. (In Russ.)

2. Ivashkin V.T., Shelygin Yu.А., Khalif I.L., Belousova E.А., Shifrin O.S., Аbdulganieva D.I., Аbdulkhakov R.А. et al. Guidelines of the Russian Gastroenterological Association and the Russian Association of Coloproctologists for the diagnosis and treatment of Crohn's disease. Koloproktologiya, 2017, vol. 2, no. 60, pp. 7-29. (In Russ.)

3. Ananthakrishnan A.N., Attila T., Otterson M.F., Lipchik R.J., Massey B.T., Komorowski R.A., Binion D.G. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease. J. Clin. Gastroenterol., 2007, vol. 41, no. 7, pp. 682-688.

4. Bachmann O., Länger F., Rademacher J. Pulmonary manifestations of inflammatory bowel disease. Internist, 2010, vol. 5, no. 1, pp. 264-268.

5. Basseri B., Enayati P., Marchevsky A., Papadakis K.A. Pulmonary manifestations of inflammatory bowel disease: case presentations and review. J. Crohns Colitis, 2010, vol. 4, pp. 390-397.